Linking extraordinary people like you with the nation's most promising research.
Founded by Our Blood Institute in 2015, BioLinked presents an easy way for our incredible donors to save lives and contribute to medical breakthroughs through clinical research uniquely tailored to them.
In less than a decade, OBI donors who have participated in BioLinked have helped advance medicine in some amazing ways. Here are just a few:
It takes about five minutes to create a BioLinked Registry profile. After that, just fill out a brief health questionnaire and someone from OBI will contact you the next time the right research opportunity becomes available.
Interested but need more information? Make sure to visit BioLinked's Frequently Asked Questions page. Hover over the "For Participants" section and you will find helpful answers about the types of studies available, payment details and more.
Not ready to sign up for BioLinked? That’s OK! New research opportunities are regularly posted to our Research & Innovation page and in the section below. Many offer reimbursement for time and travel, and all of them are dependent on people like you. Prospective participants can call 405-212-1176 and a member of our R&D team will answer any questions you have and get you scheduled.
All of Us is an exciting program from the National Institutes of Health. The mission of the program is simple: to speed up health research. And they’re asking one million or more people to lead the way.
Apheresis procedures like plateletpheresis
The cells that are collected are used by researchers and biotech companies to develop immune cell-based cancer therapies
Some of the donations are used as the staring material for a immune cell based drug that is undergoing clinical trials in patients
Apheresis procedures like plateletpheresis
Prior to procedure, donors are given subcutaneous injections of a growth factor that causes immature blood cells to be released from the bone marrow into the circulating blood
The cells that are collected are used by researchers and biotech companies to develop immune cell-based cancer therapies
Some of the donations are used as the starting material for a immune cell-based drug that is undergoing clinical trials in patients
The amount of blood removed is the same volume as occurs in a normal blood donation
These products are used to harvest mesenchymal stromal cells, which are used to promote growth in damaged tissue
Donors are admitted to a local surgery center
Donors are given conscious sedation anesthesia. The donor is asleep, but not sedated to a level that requires a breathing tube
A special needle is inserted into the hip and bone marrow is removed
Donors are screened for high levels of a specific blood factor
Selected donors are asked to donate plasma
Research-specific samples drawn from relevant populations
Requirements vary